Discovery, production and modification of 5 novel lantibiotics using the promiscuous nisin modification machinery

Auke J. van Heel, Tomas G. Kloosterman, Manuel Montalban-Lopez, Jingjing Deng, Annechien Plat, Babtiste Baudu, Djoke Hendriks, Gert N. Moll, Oscar P. Kuipers

Research output: Contribution to journalArticleAcademicpeer-review

70 Citations (Scopus)
144 Downloads (Pure)

Abstract

To find the right conditions to isolate natively expressed antimicrobial peptides from a wide range of different microorganisms can be a challenge. Here, we exploited a heterologous expression system to produce and characterize several novel lantibiotics. We identified 55 novel putative class I and class II lantibiotics after inspecting all publicly available prokaryotic genomes using the in-house developed mining tool BAGEL3. The genes encoding these new lantibiotics fused to the nisin leader peptide gene sequence were synthesized and the constructs were plugged into the nisin expression and modification system. Using this approach 30 peptides could be expressed, 27 of which were dehydrated by NisBC on at least 1 predicted position. Good antimicrobial activity against several pathogenic bacteria could be demonstrated for 5 novel heterologously modified lantibiotics. Lantibiotics from Corynebacterium lipophiloflavum DSM 44291 and Streptococcus agalactiae ATCC 13813, named flavucin and agalacticin, respectively, were fully modified and displayed high antimicrobial activity. The efficiency of functional expression was significantly enhanced when we made use of the native nisin leader cleavage site, instead of an artificial factor Xa site. Thus, we describe an efficient way for heterologous production of active lantipeptides, facilitating a rapid identification of promising molecules.

Original languageEnglish
Article number6b00033
Pages (from-to)1146-1154
Number of pages9
JournalACS Synthetic Biology
Volume5
Issue number10
DOIs
Publication statusPublished - 13-Jun-2016

Fingerprint

Dive into the research topics of 'Discovery, production and modification of 5 novel lantibiotics using the promiscuous nisin modification machinery'. Together they form a unique fingerprint.

Cite this